ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 4

The Influence of Adipokines on the Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Endothelial Cells

Rebecca Hasseli1, Klaus W. Frommer2, Thomas Dr. Umscheid3, Markus Prof. Dr. Schönburg4, Stefan Rehart5, Ulf Müller-Ladner2 and Elena Neumann2, 1Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 2Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 3William Harvey Klinik; Bad Nauheim, Germany, Bad Nauheim, Germany, 4Department of Cardiac Surgery; Kerckhoff-Klinik, Bad Nauheim, Bad Nauheim, Germany, 5Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adhesion molecules, Adipokines, endothelial cells, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid Arthritis (RA) is a systemic chronic inflammatory disease. Adipose tissue, being an endocrine organ, plays an important role in inflammatory processes. Adipokines are immunomodulatory factors mainly secreted by the adipose tissue. In previous studies we could show that RA synovial fibroblasts (SF) are able to migrate long distances in vivo via the vasculature. Therefore, we analysed the role of adipokines on RASF and endothelial cell (EC) adhesion and interaction. Static and dynamic adhesion as well as the expression of selected adhesion molecules on RASF and EC after stimulation with adipokines (adiponectin, visfatin, resistin), glucocorticoids and methotrexate (MTX) were evaluated.

Methods:

Primary RASF and EC were stimulated with adiponectin (10 µg/ml), visfatin (100 ng/ml) and resistin (20 ng/ml) as well as with MTX (1.5 µM) and the glucocorticoids prednisolone (1 µM) and dexamethasone (1 µM). The interaction of both cell types under static conditions using a cell-to-cell-binding assay was analyzed. RASF adhesion to E-selectin was studied in a flow adhesion assay (flow rates: 18.4/30.5/60.5 ml/h) as flow conditions are required for selectins to be obtain their active conformation. The expression of selected adhesion molecules on RASF and EC after adipokine./MTX/glucocorticoid stimulation was analyzed by real-time PCR.

Results:

Prednisolone stimulation down-regulated mRNA expression of VCAM-1 (-3.3-fold) in RASF (n=3), which was also reduced after dexamethasone stimulation (‑8.3‑fold). TNF-α used as proinflammatory control increased ICAM-1 mRNA expression (46.5 fold), while P‑selectin mRNA expression (-7.7-fold) was decreased in EC (n=3).Under static conditions, the adipokines increased adhesion of RASF to EC (Ad: 37%, Vis: 23%, Res: 32%; n=6), while prednisolone and MTX caused a minor decrease (-7% for both; n=4). Dexamethasone did not change RASF adhesion to EC under static conditions. Under flow conditions, visfatin increased RASF adhesion to E-selectin (28%/87%/29%; n=3 for each flow rate), while dexamethasone decreased their adhesion to E-selectin (-33%/-35%/-41%; n=3 for each flow rate).

Conclusion:

Adipokines have an influence on the cellular expression of adhesion molecules on RASF and EC as well as their interaction. Adipokines increase adhesion of RASF to EC and therefore influence RASF migration. Therapeutics such as glucocorticoids and MTX antagonized these effects, which may represent a mechanism of the protective effects of these drugs observed in patients. Evaluation of the immunomodulatory role of adipokines and therapeutics in the pathogenesis and progression of RA may help to understand new metabolic-inflammatory pathways active in chronic inflammatory diseases such as RA.


Disclosure: R. Hasseli, None; K. W. Frommer, None; T. Dr. Umscheid, None; M. Prof. Dr. Schönburg, None; S. Rehart, None; U. Müller-Ladner, None; E. Neumann, None.

To cite this abstract in AMA style:

Hasseli R, Frommer KW, Umscheid T, Schönburg M, Rehart S, Müller-Ladner U, Neumann E. The Influence of Adipokines on the Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Endothelial Cells [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-influence-of-adipokines-on-the-interaction-of-rheumatoid-arthritis-synovial-fibroblasts-with-endothelial-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-influence-of-adipokines-on-the-interaction-of-rheumatoid-arthritis-synovial-fibroblasts-with-endothelial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology